Angiopoietin-Like 4 Mediates PPAR Delta Effect on Lipoprotein Lipase-Dependent Fatty Acid Uptake but Not on Beta-Oxidation in Myotubes

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Robciuc, Marius R ^a   Skrobuk, Paulina ^b,c,d   Anisimov, Andrey ^e   Olkkonen, Vesa M ^b,f   Alitalo, Kari ^e   Eckel, Robert H ^g   Koistinen, Heikki A ^b,c,d   Jauhiainen, Matti ^a   Ehnholm, Christian ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; BEXAROTENE; BOVINE SERUM ALBUMIN; FATTY ACID; INSULIN; LIPOPROTEIN LIPASE; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; MALE; MOUSE; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ANGIOPOIETINS; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; FATTY ACIDS; GENE EXPRESSION; HUMANS; LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; OXIDATION-REDUCTION; PALMITATES; PPAR DELTA; RATS; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TETRAHYDRONAPHTHALENES; THIAZOLES;

RATTUS;

EID: 84867132145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046212     Document Type: Article

References (42)

1. Samuel VT, Petersen KF, Shulman GI, (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375: 2267-2277.
2. Goldberg IJ, Eckel RH, Abumrad NA, (2009) Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res 50 (Suppl):: S86-90.
3. Davies BS, Beigneux AP, Barnes RH 2nd, Tu Y, Gin P, et al. (2010) GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab 12: 42-52.
4. Young SG, Davies BS, Voss CV, Gin P, Weinstein MM, et al. (2011) GPIHBP1, an endothelial cell transporter for lipoprotein lipase. J Lipid Res.
5. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, et al. (2002) Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem 277: 26089-26097.
6. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, et al. (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100: 15924-15929.
7. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, et al. (2003) Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113: 159-170.
8. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, et al. (2003) Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta 1633: 43-50.
9. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, et al. (2003) Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17: 2299-2301.
10. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, et al. (2003) The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17: 2477-2493.
11. Staiger H, Haas C, Machann J, Werner R, Weisser M, et al. (2009) Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 58: 579-589.
12. Yoshida K, Shimizugawa T, Ono M, Furukawa H, (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43: 1770-1772.
13. Lichtenstein L, Kersten S, (2010) Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1. Biochim Biophys Acta 1801: 415-420.
14. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, et al. (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281: 934-944.
15. Robciuc MR, Naukkarinen J, Ortega-Alonso A, Tyynismaa H, Raivio T, et al. (2011) Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins. J Lipid Res 52: 1575-1582.
16. Gray NE, Lam LN, Yang K, Zhou AY, Koliwad S, et al. (2012) Angiopoietin-like 4 (Angptl4) is a physiological mediator of intracellular lipolysis in murine Adipocytes. J Biol Chem.
17. Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, et al. (2003) Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 60: 991-998.
18. Poirier P, Marcell T, Huey PU, Schlaepfer IR, Owens GC, et al. (2000) Increased intracellular triglyceride in C(2)C(12) muscle cells transfected with human lipoprotein lipase. Biochem Biophys Res Commun 270: 997-1001.
19. Paterna JC, Moccetti T, Mura A, Feldon J, Bueler H, (2000) Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther 7: 1304-1311.
20. Anisimov A, Alitalo A, Korpisalo P, Soronen J, Kaijalainen S, et al. (2009) Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res 104: 1302-1312.
21. Robciuc MR, Tahvanainen E, Jauhiainen M, Ehnholm C, (2010) Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J Lipid Res 51: 824-831.
22. Huttunen JK, Ehnholm C, Kinnunen PK, Nikkila EA, (1975) An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 63: 335-347.
23. Hirschey M, Verdin E, (2010) Measuring fatty acid oxidation in tissue homogenates. Protocol Exchange 10: 1038.
24. Rune A, Salehzadeh F, Szekeres F, Kuhn I, Osler ME, et al. (2009) Evidence against a sexual dimorphism in glucose and fatty acid metabolism in skeletal muscle cultures from age-matched men and post-menopausal women. Acta Physiol (Oxf) 197: 207-215.
25. Somwar R, Sweeney G, Ramlal T, Klip A, (1998) Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells. Clin Ther 20: 125-140.
26. Sznaidman ML, Haffner CD, Maloney PR, Fivush A, Chao E, et al. (2003) Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)-synthesis and biological activity. Bioorg Med Chem Lett 13: 1517-1521.
27. Ge H, Yang G, Huang L, Motola DL, Pourbahrami T, et al. (2004) Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem 279: 2038-2045.
28. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, et al. (2001) Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 98: 7522-7527.
29. Wang H, Knaub LA, Jensen DR, Young Jung D, Hong EG, et al. (2009) Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes 58: 116-124.
30. Georgiadi A, Lichtenstein L, Degenhardt T, Boekschoten MV, van Bilsen M, et al. (2010) Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ Res 106: 1712-1721.
31. Lichtenstein L, Mattijssen F, de Wit NJ, Georgiadi A, Hooiveld GJ, et al. (2010) Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab 12: 580-592.
32. Varga T, Czimmerer Z, Nagy L, (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 1812: 1007-1022.
33. Assaf C, Bagot M, Dummer R, Duvic M, Gniadecki R, et al. (2006) Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. Br J Dermatol 155: 261-266.
34. Davies PJ, Berry SA, Shipley GL, Eckel RH, Hennuyer N, et al. (2001) Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol Pharmacol 59: 170-176.
35. Haugen BR, Jensen DR, Sharma V, Pulawa LK, Hays WR, et al. (2004) Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet. Endocrinology 145: 3679-3685.
36. Klopper JP, Berenz A, Hays WR, Sharma V, Pugazhenthi U, et al. (2008) In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma. Clin Cancer Res 14: 589-596.
37. Smart-Halajko MC, Robciuc MR, Cooper JA, Jauhiainen M, Kumari M, et al. (2010) The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler Thromb Vasc Biol 30: 2277-2282.
38. Sonnenburg WK, Yu D, Lee EC, Xiong W, Gololobov G, et al. (2009) GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J Lipid Res 50: 2421-2429.
39. Yamada T, Ozaki N, Kato Y, Miura Y, Oiso Y, (2006) Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes. Biochem Biophys Res Commun 347: 1138-1144.
40. Farese RV Jr, Yost TJ, Eckel RH, (1991) Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 40: 214-216.
41. Wang H, Eckel RH, (2009) Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 297: E271-288.
42. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, et al. (2005) Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A 102: 6086-6091.